Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer

Perets, R; Bar, J; Rasco, DW; Ahn, MJ; Yoh, K; Kim, DW; Nagrial, A; Satouchi, M; Lee, DH; Spigel, DR; Kotasek, D; Gutierrez, M; Niu, J; Siddiqi, S; Li, X; Cyrus, J; Chackerian, A; Chain, A; Altura, RA; Cho, BC

Cho, BC (corresponding author), Yonsei Canc Ctr, 50-1 Yonsei Ro, Seoul, South Korea.

ANNALS OF ONCOLOGY, 2021; 32 (3): 395

Abstract

Background: Quavonlimab (MK-1308), a novel anti-CTLA-4 antibody, in combination with pembrolizumab was investigated in a phase I study. Patients and m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索